Search

US approves 1st drug developed to prevent chronic migraines

US APPROVES 1ST DRUG DEVELOPED TO PREVENT CHRONIC MIGRAINES

This May 10, 2018, image provided by Amgen Inc. shows an artist's rendering of the packaging for the drug Aimovig, the first in a new...

 
 
 
Akili Grabs $55M, Seeking FDA Approval of First Video Game Therapy

AKILI GRABS $55M, SEEKING FDA APPROVAL OF FIRST VIDEO GAME THERAPY

Akili Interactive Labs has scooped up another pile of cash to help bring its first product to the market-an experimental mobile video...

 
 
 
 
 
 
Teva Migraine Drug Likely Delayed by Manufacturing Trouble

TEVA MIGRAINE DRUG LIKELY DELAYED BY MANUFACTURING TROUBLE

Teva Pharmaceutical's bid to bring a new migraine drug to the market faces a possible delay due to manufacturing problems found with...

 
 
 
Alder Plans for FDA Filing After Migraine Drug Posts Strong Results

ALDER PLANS FOR FDA FILING AFTER MIGRAINE DRUG POSTS STRONG RESULTS

Alder Therapeutics' migraine-prevention drug hit its main goal in a late-stage study, and the drug developer these early results keep...

 
 
 
First Video Game Therapy Heads to FDA As Akili Touts ADHD Study Win

FIRST VIDEO GAME THERAPY HEADS TO FDA AS AKILI TOUTS ADHD STUDY WIN

For the first time ever, a mobile video game used to assess and treat a disease is headed for an FDA review. Akili Interactive Labs,...

 
 
 
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More

BIO ROUNDUP: MIGRAINE DATA, CANCER DRUG COMBOS, AZAR HEARING & MORE

A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency...

 
 
 

ATLAS, AMGEN, LILLY BACK KYMERA'S $30M SERIES A

Atlas-incubated Kymera Therapeutics has gotten off a $30 million series A and taken on Pierre Fabre's R&D head as its new chief.

 
 
 
Injection may help people lose 10% of their weight

INJECTION MAY HELP PEOPLE LOSE 10% OF THEIR WEIGHT

Researchers based in Amgen's LA office also found that when given to monkeys, the injection improved their blood glucose levels, which...

Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More

BIO ROUNDUP: NOBEL PURSUIT, FUNDRAISING FRUIT, A RHYTHMIC IPO & MORE

The 2017 Nobel Prizes with a biomedical bent were announced this week. Three researchers shared the physiology and medicine prize for...

 
 
 
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More

BIO ROUNDUP: GRAHAM-CASSIDY, AXOVANT FAIL, SPRINGWORKS LAUNCHES & MORE

After drug pricing, count drug shortages among the hot button issues sparking patient ire. Last year, the FDA says, 23 drug shortages...

Eyeing a Comeback, Arrowhead Bets on New RNAi Delivery Tool

EYEING A COMEBACK, ARROWHEAD BETS ON NEW RNAI DELIVERY TOOL

Following a series of setbacks late last year, Arrowhead Pharmaceuticals, one of the companies trying to develop drugs using RNA interference,...